摘要:
The present invention relates to a vaccine for immunization against a viral infection caused by a virulent systemic feline calicivirus (VS-FCV), a novel, atypical and unusually virulent form of a calicivirus that results in a highly contagious and fatal hemorrhagic fever syndrome. The present invention further encompasses methods of immunizing cats against particular strains of VS-FCV.
摘要:
The invention concerns immunogenic preparations and vaccines, in particular inactivated, efficient against feline calicivirus disease, based on strain 431 FCV virus as filed at the CNCM under access number CNCM I-2166, or one of its equivalents, in a carrier or excipient acceptable in veterinary medicine, preferably associated with the FCV virus derived from another FCV strain, in particular the G1 strain as filed at the CNCM under access number CNCM I-2167. The invention also concerns the hybridoma filed under access number CNCM I-2282, and the monoclonal antibody produced by said hybridoma.
摘要:
The present invention relates to a vaccine for immunization against a viral infection caused by a virulent systemic feline calicivirus (VS-FCV), a novel, atypical and unusually virulent form of a calicivirus that results in a highly contagious and fatal hemorrhagic fever syndrome. The present invention further encompasses methods of immunizing cats against particular strains of VS-FCV.
摘要:
The invention provides for methods of viral inactivation using high temperature short time (HTST) treatment and adjustment of various parameters such that generation of precipitate and depositions of precipitate are reduced and/or minimized.
摘要:
The invention concerns immunogenic preparations and vaccines, in particular inactivated, efficient against feline calicivirus disease, based on strain 431 FCV virus as filed at the CNCM under access number CNCM I-2166, or one of its equivalents, in a carrier or excipient acceptable in veterinary medicine, preferably associated with the FCV virus derived from another FCV strain, in particular the G1 strain as filed at the CNCM under access number CNCM I-2167. The invention also concerns the hybridoma filed under access number CNCM I-2282, and the monoclonal antibody produced by said hybridoma.
摘要:
The invention provides for methods of viral inactivation using high temperature short time (HTST) treatment and adjustment of various parameters such that generation of precipitate and depositions of precipitate are reduced and/or minimized.
摘要:
The invention provides for methods of viral inactivation using high temperature short time (HTST) treatment and adjustment of various parameters such that generation of precipitate and depositions of precipitate are reduced and/or minimized.
摘要:
The present invention relates to a vaccine for immunization against a viral infection caused by a virulent systemic feline calicivirus (VS-FCV), a novel, atypical and unusually virulent form of a calicivirus that results in a highly contagious and fatal hemorrhagic fever syndrome. The present invention further encompasses methods of immunizing cats against particular strains of VS-FCV.